ACNE

 

ACNE & HIGH GLYCAEMIC DIET

---

The Global Burden of Disease (GBD) study done in 2010 by Hay et al., (2014) deduced that acne vulgaris affects ~85% of young adults aged 12–25 years and is the 8th most prevalent disease globally (Institute for Health Metrics and Evaluation, 2016).

Many large studies conducted on the general population and young adults have reported that acne is the third most prevalent skin condition throughout the world (Lynn, Umari, Dunnick & Dellavalle,2016) and have identified Propionibacterium acnes, hyperkeratosis, increased sebaceous lipogenesis, androgen dependence and localized inflammation as the main pathophysiological causes of acne (Melnik,2010).

Recent studies have shown a relationship between acne and nutritional factors suggesting that high-glycaemic-load diets might exacerbate acne vulgaris.

Glycaemic index(GI) of a food item is the ranking of how quickly each carbohydrate based food item makes blood sugar levels rise after eating them (Lynn et al., 2016). Glycaemic index ranges from 0-100 with slowly absorbed carbohydrates having a low GI rating of 55 or less and including most fruits, vegetables, whole grain cereals and pulses (Diabetes UK,2017). Melnik (2015) proposed that a high glycaemic index diet including glucose, white bread and white rice, induces hyperinsulinemia, which in turn stimulates endocrine responses, enhances androgen synthesis and subsequently affects development of acne through mediators such as androgens, insulin-like growth factor (IGF)-1, and IGF binding protein (IGFBP)-3.

How do we treat acne at SK!N?

-Medications such as antibiotics, retinoids, dicarboxylic acids, etc.

-Chemical peels- Salicylic acid, AZELAN , ACNELAN 

-Microneedling

-Diamond Tip Dermalinfusion with Advanced Pro Serums

–Fire and Ice Facial 

-Laser therapy

-Good home care

-DIET CONTROL

-Neo Elite Laser

Hello NeoElite. Goodbye Acne.

CLICK HERE TO SCHEDULE A CONSULTATION WITH US

NeoElite by Aerolase®
Drug-Free Acne Clearance

NeoClear by Aerolase acne therapy is the perfect solution for all ages and all skin types who suffer from all severities of acne. This safe, effective, and tolerable treatment is quickly becoming the ‘go-to’ treatment for patients suffering from acne.

What is NeoClear and How Does it Work?

Neo Elite by Aerolase offers patients of all ages and skin types a new safe, effective, and tolerable treatment for acne using advanced 650-microsecond technology. NeoElite is a powerful acne treatment that eliminates the major factors causing acne including excess sebum production, inflammation, and the p. acnes bacteria. Typically, many different treatments, medications, or skin care options are required to address these factors, but NeoClear can achieve this with a single device. The unique settings of the 650-microsecond device allows energy to penetrate deeply into the skin within a highly safe and tolerable pulse to reduce sebum production, suppress inflammation, and destroy the p. acnes bacteria to help clear current acne breakouts and to stop them in the future. Also, the deep heating energy helps build collagen, which can reduce the appearance of acne scars and leave skin looking radiant. 

NeoClear is a special treatment as there are no side effects, is very comfortable for patients, and the results can be seen quickly – in as little as a single treatment. NeoClear is an excellent option for patients that do not want to take prescription medications or are unable to. Plus, with increasing prescription costs, NeoClear is an excellent, cost-effective solution for patients’ acne problems. 

NeoClear treatments typically take between 10-30 minutes depending on the severity of acne and the size of the area affected (face, neck, chest, torso). NeoClear is highly safe, effective, and tolerable for all skin types, all ages, and all types of acne. Treatment may be performed without any skin cooling, anesthetic, and even without the need to touch the skin. 

If you’d like to find out more about NeoClear by Aerolase, please visit NeoClearbyAerolase.com

References:

Hay, R. J., Johns, N.E., Williams, H. C., Bolliger, I.W., Dellavalle, R.P., Margolis, D.J., Marks, R., Naldi, L., Weinstock, M.A., Wulf, S.K., Michaud, C., Murray, C.J.L. & Naghavi, M. (2014). The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions, Journal of Investigative Dermatology, 134(6),1527-1534.

Institute for Health Metrics and Evaluation (2016). GBD Compare Data Visualization. Seattle: Institute for Health Metrics and Evaluation, University of Washington. Retrieved on April 14, 2017 from http:// vizhub.healthdata.org/gbd-compare.

Lynn, D. D., Umari, T., Dunnick, C. A., & Dellavalle, R. P. (2016). The epidemiology of acne vulgaris in late adolescence. Adolescent Health, Medicine and Therapeutics, 7, 13–25. Retrieved on April 11, 2017 from http://doi.org/10.2147/AHMT.S55832

Melnik, B. C. (2010). FoxO1 – the key for the pathogenesis and therapy of acne ?. Journal der Deutschen Dermatologischen Gesellschaft, 8, 105–114.

Melnik, B. C. (2015). Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clinical, Cosmetic and Investigational Dermatology 8, 371–388.